Actively Recruiting
Assessment of the Diagnostic Accuracy and Performance of the UllCORE Bloodstream Infection Test in Patients with Suspected Sepsis or Bloodstream Infection
Led by Deepull Diagnostics S.L. · Updated on 2026-10-08
1500
Participants Needed
20
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the clinical performance of the UllCORE Bloodstream Infection BSI Test, a new molecular diagnostic tool designed to detect microorganisms and certain antimicrobial resistance markers directly from whole blood in patients suspected of having bloodstream infections or sepsis. This observational study compares the UllCORE BSI Test results with standard blood culture and microbiology testing methods to assess its diagnostic accuracy. Participants with suspected bloodstream infection or sepsis will have blood samples collected simultaneously for standard-of-care blood culture testing and for the investigational UllCORE BSI Test. The test may be performed on fresh blood samples or samples stored frozen according to the study protocol. The investigational test results will not be used to guide patient care or clinical decisions during the study. During participation, blood will be collected once alongside routine blood culture samples. The investigational test results will be compared with standard microbiology results and additional testing when applicable, up to one year after collection. No changes to standard medical care will occur, and participants will be observed only. The primary measure is the diagnostic agreement between the UllCORE BSI Test and standard-of-care methods over this period.
CONDITIONS
Brief Title
Evaluation of Diagnostic Accuracy and Clinical Performance of the UllCORE Bloodstream Infection (BSI) Test
Research Team
R
Roger Canton
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here